Fungal disease in the immunocompromised host.
A variety of superficial and deep mycoses may affect the immunocompromised patient. Among the superficial mycoses, candidal infections are common in all groups, but dermatophyte and pityrosporum infections may also be found. Although not primarily dangerous, they may lead to secondary bacterial infections and morbidity. Of the systemic mycoses, candidiasis, aspergillosis, and mucor-mycosis are frequently lethal and require early diagnosis and aggressive antifungal treatment. Endemic mycoses, such as histoplasmosis and coccidioidomycosis, may result in severe and often fatal infections in those patients with cellular immune alterations. The identification and prophylaxis of high-risk patients and the development of more effective antifungal therapies are beginning to have an impact on the control of fungal disease in this population.
Myskowski
P L
PL
Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
White
M H
MH
Ahkami
R
R
D003881:Dermatomycoses / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D012307:Risk Factors